EDT — Spectral Medical Share News
0.000.00%
Last trade - 00:00- CA$324.10m
- CA$348.98m
- CA$2.44m
Brief: Spectral Medical Enters Into An Agreement With Infomed SA To Extend Its License For CRRT Market
Brief: Spectral Announces Approval Of Tigris Trial By The US FDA
Brief: Spectral To Update Timing For Initiation Of Tigris Trial In Near Future
Brief: Spectral Enters Into Technology Transfer Transaction And Provides Update On US FDA Process
Brief: Spectral Reports Qtrly Loss Per Share $0.007
Brief: Spectral Announces Successful Manufacturing Audit Of Toray By The US FDA
Brief: Spectral Says In Dialogue With US FDA For Collection Of More Information Regarding Safety And Efficacy For PMX Cartridge
Brief: Spectral Medical Posts Q1 Loss Of C$0.003 Per Share
Brief: Spectral Medical Q4 Loss Per Share $0.006
Brief: Spectral Medical Spectral Says Health Canada Approved Its Pump For Use In CRRT And Hemoperfusion
Brief: Spectral Medical says Richard Wieland II Appointed Interim CFO
Brief: Spectral Medical Says FDA Granted 510(K) Clearance For Proprietary Stand-Alone Pump
Brief: FDA Grants 510(K) Clearance For Spectral's Proprietary Stand-Alone Pump
Brief: Spectral Medical To Launch Toraymyxin/EAA In Canada In Q1 2018
Brief: Spectral posts Q3 loss per share c$0.004
Brief: Spectral Medical reports Q3 loss per share $0.004
Brief: Spectral provides update on FDA meeting regarding PMA submission for toraymyxin
Brief: Spectral announces retirement of chief financial officer
Brief: Spectral provides regulatory update on its PMA submission for Toraymyxin